Although viral upper respiratory infections (URIs) provoke wheezing in many asthma patients, the effect of these illnesses on the airway response to inhaled antigen is not established. The following study evaluated the effect of an experimental rhinovirus (RV) illness on airway reactivity and response to antigen in 10 adult ragweed allergic rhinitis patients. Preinfection studies included measurements of airway reactivity to histamine and ragweed antigen. Furthermore, the patients were also evaluated for late asthmatic reactions (LARs) to antigen (a 15% decrease in forced expiratory volume of the first second -6 h after antigen challenge). 1 mo after baseline studies, the patients were intranasally inoculated with live RV16. All 10 patients were infected as evidenced by rhinovirus recovery in nasal washings and respiratory symptoms. Baseline FEVI values were stable throughout the study. During the acute RV illness, there was a significant increase in airway reactivity to both histamine and ragweed antigen (P = 0.019 and 0.014, respectively). Before RV inoculation, only 1 of the 10 subjects had an LAR after antigen challenge. However, during the acute RV illness, 8 of 10 patients had an LAR (P < 0.0085 compared with baseline); the development of LARs was independent of changes in airway reactivity and the intensity of the immediate response to antigen. Therefore, we found that not only does a RV respiratory tract illness enhance airway reactivity, but it also predisposes the allergic patient to develop LARs, which may be an important factor in virus-induced bronchial hyperresponsiveness.
Introduction
Upper respiratory infections (URIs)' trigger wheezing in many asthma patients (1) (2) (3) (4) . Epidemiological studies have demonstrated that viral, not bacterial, respiratory infections precipi- 1 . Abbreviations used in this paper: FEF25-75%, forced midexpiratory flow rate; FEV1, forced expiratory volume of the first second; FVC, forced vital capacity; HR, histamine release; LAR, late asthmatic reaction; PD20, 20% provocative dose; Pipes, piperazine-NN'-bis(2-ethanesulfonic acid); Pipes-CM, Pipes plus 1 mM Ca2' and 1 mM Mg2+; RV, rhinovirus; TCID50, 50% tissue culture infective dose; URI, upper respiratory infection. tate these asthma attacks. Furthermore, the respiratory virus identified with increased asthma is largely determined by the age of the patient. Wheezing in infants and young children is most commonly associated with respiratory syncytial virus infections, whereas older asthma patients have similar exacerbations, but in this age group, rhinovirus (RV) infections are often precipitants (3) . Although the infectious etiology of these wheezing episodes has been determined, mechanisms to explain asthma attacks with respiratory infections remain to be established (5) .
A number of mechanisms have been proposed to explain virus-induced asthma, including airway injury by the infectious pathogen (6, 7) , diminished beta adrenergic function (8-1 1), production of virus-specific IgE-antibodies (12) (13) (14) , and enhanced leukocyte histamine release (15, 16) . High titers of IgE-antibodies to respiratory syncytial virus and parainfluenza virus are found in children with asthma-like illnesses; these individuals are more prone to recurrent episodes of wheezing (12) (13) (14) . The precise role of virus-specific IgE antibodies to the pathogenesis of airway hyperreactivity, or asthma, has yet to be clarified. Nonetheless, the potential contribution of immediate hypersensitivity reactions to virus-induced wheezing is highly likely as products of the pulmonary mast cell can be linked to acute bronchospasm, persistent bronchial inflammation, and increased airway reactivity as illustrated by the development of late asthmatic reactions (LARs) ( 17) .
This study examined the effects that an RV respiratory infection has on airway reactivity and the pattern of pulmonary response that develops after aerosolized antigen challenge.
Methods
Patient selection. 10 patients were selected for study. There were eight males and two females with an average of30.6±2.2 (mean + SE) yr. All patients had a positive immediate skin test reaction by the prick method to an extract of ragweed antigen (1/20 wt/vol, Greer Laboratories, Lenoir, NC), released leukocyte histamine after an in vitro incubation with ragweed antigen E, and lacked neutralizing antibody in their sera to rhinovirus 16 (RV 16) . None of the patients smoked, had active clinical asthma, or used any medication at the time of study. All patients gave informed consent before enrolling in the study, which was conducted during periods when the patients were free of allergic rhinitis symptoms.
For a number of reasons, we first chose to evaluate the effects of an RV illness in allergic rhinitis subjects rather than asthma patients. First, although patients with allergic rhinitis do not have clinical asthma, their airway responsiveness is often enhanced when compared with normal patients (18) . Second, in patients with allergic rhinitis, it would be unlikely to find abnormal airway smooth muscle with characteristics similar to those noted in asthma (e.g., hypertrophy, hyper-terpretation of changes in airway function. Finally, we were concerned that an acute airway infection could provoke an attack of wheezing in patients with underlying asthma.
Study design. The patients were studied on three separate occasions, each 28 d apart, as indicated by the schematic protocol in Fig. 1 Leukocyte separation procedure. Blood was obtained by venipuncture and anticoagulated with EDTA, 0.5 ml 2.7% EDTA per 9.5 ml of blood, before separation by density gradient centrifugation on FicollHypaque cushions (19) . The mononuclear cell band containing basophils was removed, washed three times with Pipes-CM (1 mM Ca2+ and 1 mM Mg2' pH 7.4) and then suspended in Pipes-CM. PMNs were then isolated after dextran sedimentation and hypotonic lysis of contaminating erythrocytes before suspension in HBSS. Cell viability for all experiments was indicated by > 95% exclusion of trypan blue dye.
Measurement of leukocyte histamine release. Isolated leukocyte suspensions (2-4 X 10 cells/ml) containing basophils were added to 10 X 75 mm plastic tubes (Falcon Labware, Oxnard, CA) in 0.5-ml replicate samples. After temperature equilibration (370C for 10 min), ragweed antigen E, freshly prepared Con A, or the calcium ionophore A23 187 was added to the leukocyte suspensions. After a 30-min incubation, the reaction was terminated by immersion of the leukocytecontaining test tubes into an ice-water bath for 10 min followed by rapid centrifugation for 1.5 min (Serofuge; Clay Adams Div., BectonDickinson & Co., Parsippany, NJ). The supernatants were removed for measurement of histamine. Total leukocyte histamine was determined after cell suspension in 3% perchloric acid.
Histamine analyses were performed by an automated fluorometric technique that uses the organic extraction of histamine and its linkage to o-phthalaldehyde (20, 21) . The percent histamine release (HR) was calculated by the following formula: % HR = 100 X (experimental supernatant HR-blank/total leukocyte histamine-blank). The blank, or spontaneous histamine release, never exceeded 6% of the total histamine when performed in calcium-containing buffer. This method is sensitive to 5.0 ng/ml of histamine.
Bronchial provocation tests. Airway reactivity to histamine and ragweed antigen was determined in the 10 patients by standard bronchial provocation techniques to increasing concentrations of either histamine or ragweed antigen aerosol delivered through a nebulizer (DeVilbiss Co., Somerset, PA) attached to a French-Rosenthal dosimeter (22 Measurement ofplasma histamine in relationship to antigen-provoked airway obstruction. To determine the effect ofantigen inhalation on airway function and changes in plasma histamine, the protocol below was followed. On the day of antigen bronchoprovocation, an intravenous catheter was placed in the left antecubital fossa vein before beginning any inhalation. Approximately 10 min after the catheter was inserted, two plasma samples were obtained, which served as baseline sources for plasma histamine. When cumulative doses of inhaled antigen caused a 20% drop in FEVI (determined 10 min after antigen delivery), another 10 ml of blood was drawn with repeat samples 5, 10, and 15 min later. The blood was immediately anticoagulated with 50 Ml of a 0.5 M EDTA solution, placed in ice, and then centrifuged. The plasma was frozen (-80'C) and later analyzed for histamine by a radioenzymatic assay as described previously (23) . This assay uses histamine N-methyltransferase and S-adenosyl-C-[3H-methyl]-methionine to convert histamine to [3Hltele-methylhistamine, which is then isolated from other radiolabeled material and finally quantitated by liquid scintillation. Standard curves were prepared for each experiment with histamine concentrations from 15 to 5,000 pg/ml (linear coefficient of variance equal to 0.99) and used to calculate the plasma histamine concentration. This method has greater sensitivity than the fluorometric technique to measure plasma histamine.
Serum IgE determinations. Serum IgE values were determined by a double-antibody, solid-phase, ELISA (Enzygnost IgE; CalbiochemBehring Corp., La Jolla, CA).
RV16 inoculation. The technique for rhinovirus inoculation followed previously described methods (24, 25) . Briefly, no patients had neutralizing antibody in their sera (< 1:1) against a 20-25 tissue culture infective dose 50% (TCID50) challenge of RV 16 . Rhinoviral colds were induced in the 10 donors by instilling, on two successive days, 0.25 ml of RV16 suspension into each nostril by pipette (320-3,200 TCID50) and then spraying approximately the same amount into each nostril with an atomizer (No. 286; DeVilbiss Co.) powered by a compressor (561 series; DeVilbiss Co.). The coarse spray coated the nasal cavity well (as visualized by a head lamp).
Colds were evaluated with a questionnaire that was completed by the participant hourly during waking hours (26 Laboratory confirmation of a viral infection. Virus shed by the inoculated subjects was assayed by titration ofa nasal wash into diploid (WI-38) cell cultures. Nasal washes were taken by instilling 5 ml of HBSS with 0.5% gelatin into each nostril, holding for 5 s, and then expelling into a sterile petri dish. Nasal washes were inoculated into WI-38, primary rhesus monkey, and HEp-2 cell cultures, and post-experimental washings into WI-38 cells only (24, 25) . Etiology was established by at least one identified isolate and/or by a fourfold or greater increase in neutralizing antibody in the convalescent serum specimens (24) . Antibody titers were expressed as initial serum dilutions in which 1:1 = undiluted serum, 1:2 = one part serum and one part diluent, etc. PMN cAMP response. The isolated suspensions of intact PMNs were suspended in a 50 mM Tris saline buffer with 8 mM theophylline at a cell concentration of 1 X 107 PMN/ml; 0.2-ml aliquots of PMN were incubated (370C) with isoproterenol (10 AM for 2 min), a time predetermined to give maximal stimulation of cAMP in the PMN. The reaction was terminated by boiling the cell suspension for 3 min. cAMP was determined by a protein binding assay as described by Brown and colleagues (27) 
Results
Results of R V16 inoculation. 9 of the 10 patients inoculated with RV16 had this virus identified in nasal washes (Table I) . Further, eight of the nine patients from whom convalescent sera were available had at least a fourfold rise in RV 1 6-specific antibody. Patient 7 moved from Wisconsin and was unavailable for convalescent testing. Patient 10 was shedding a wild RV at the time of inoculation and continued to shed this virus throughout the experiment. Because he was infected with a RV, his data were included in the study. Therefore, all 10 patients studied were considered to have a RV infection.
Effect of R V on pulmonary functions and airway responsiveness. Spirometry values (FEVy, FVC, FEF25-75%) were similar at each of the three study periods: preinfection, acute infection, and postinfection, and were ' 95% of the predicted representative values for each patient (Table II) .
During the acute RV infection, airway reactivity to histamine was significantly (P = 0.019, paired Wilcoxon Test) enhanced from baseline values (Fig. 2) . The mean value for the histamine PD20 value has a large standard error which indicates the wide range in PD20 determinations to aerosol histamine, 8.8 to 300 cumulative breath units, in the allergic rhinitis patients studied. However, only one of the patients failed to have a fall in the histamine PD20 value during the acute rhinovirus respiratory infection (patient 2). Airway reactivity to ragweed antigen was also significantly enhanced over pre-in- When airway reactivity to histamine was determined 24 h after ragweed antigen challenge, a significant (P < 0.036, paired Wilcoxon Test) enhancement in airway reactivity was noted at both baseline and during the acute RV infection (Fig.  2) . During the acute RV infection, airway reactivity to histamine, after ragweed antigen inhalation challenge, was also significantly enhanced when compared with its baseline counterpart (P = 0.014, paired Wilcoxon Test). The relative enhancement of airway reactivity to histamine after antigen challenge Seven of the patients were available for evaluation of airway reactivity 4 wk after virus infection (recovery). In these seven patients (Fig. 3) , changes in the pattern ofairway reactivity to histamine (preantigen) and ragweed antigen (baseline vs. URI) were similar to those described with all 10 patients (Fig.  2) . However, 4 wk after the acute RV infection, airway reactivity to histamine (preantigen) showed a return toward baseline value but was still significantly (P = 0.022 paired Wilcoxon Test) different than preinfection determinants. The PD20 value for antigen at recovery was less than baseline, but differences were not significant. In contrast, airway reactivity to histamine postantigen challenge remained unchanged from values during the acute URI. The individual patient responses at each study period are listed in Table II. Effect ofR V infection on the development ofLARs. After bronchoprovocation with ragweed antigen, all patients were evaluated for the development of LARs, which were defined as a 15% drop in FEVI within 6 h ofantigen challenge (Fig. 4) . At baseline (preinfection) evaluation, only I of the 10 subjects had an LAR. When the same evaluation was performed during acute RV infection, 8 of 10 subjects had LARs (P = 0.0085, McNemar's Test). Ifthe relationship between the development of an LAR was compared with indices of airway reactivity (Spearman rank correlation), no correlations were found between the LAR and PD20 values for histamine or antigen, or between changes in those values from baseline measurements. This indicated that the development of an LAR was independent of enhanced airway reactivity found during the cold. Furthermore, although there was a trend for a larger percent fall in FEVy to inhaled antigen during the URI compared with baseline (P = 0.08, Wilcoxon paired analysis; Table III Effect ofantigen provocation on airway reactivity independent ofR V infections. Because antigen provocation caused enhanced airway reactivity to aerosol histamine, we were interested in the duration of this effect independent of RV infection. In a subsequent series of experiments, seven of the allergic rhinitis subjects from this study were reevaluated. We found that the enhanced airway reactivity to histamine that follows antigen provocation lasts < 2 wk in these allergic rhinitis patients (Table IV) . Since the effects of RV on airway reactivity were evaluated 4 wk after an antigen challenge, the initial antigen challenge at baseline should not have caused enhanced bronchial responsiveness during the acute RV infection.
Effect of RV on basophil HR. Leukocyte HR to various concentrations of ragweed antigen E, Con A, and the calcium ionophore A23187 were evaluated at all three study periods. We found significant (P = 0.027, analysis of variance) enhancement of the ragweed antigen E-dependent basophil HR curves from cells studied during the acute RV infection (Fig.  5) . In contrast, HR to Con A and calcium ionophore were not changed during the RV infection (data not shown). Furthermore, when similar evaluations were made 4 wk later at recovery, leukocyte HR to ragweed antigen had returned to baseline values in some, but not all, subjects. These data were further evaluated to determine the effect respiratory infection had on various parameters of basophil HR. The antigen concentration required to achieve 50% maximal HR was similar at baseline (5.5 [± 1.4] X pi0 ,g/ml) and acute URI (3.9 [±1.4] X u0-4ig/ml). This suggests that there was no change in membrane-bound IgE antibody to ragweed during the infection. However, direct quantitation of basophil IgE was not made. Although serum levels of IgE antibody were found to be similar before (264.3±93.6 IU/ml), during (254.0±82.4 IU/ml), and 1 mo after RV infection (312.4±99.4 IU/ml) (values = mean±SEM), specific antibody to ragweed was not measured. These results are all indirect measures to assess cell bound antibody but, nonetheless, suggest no change in basophil IgE concentrations during infection.
Effect ofRV infection on plasma histamine concentrations after antigen challenge. Plasma levels of histamine obtained before antigen inhalation were higher during RV infection (286±51 pg/ml) than baseline values (185±35 pg/ml) but differences did not achieve significance (P = 0.103, paired Wilcoxon Test). The plasma histamine levels were also determined after patients had inhaled a sufficient concentration of ragweed antigen to cause a 20% drop in FEVI. Plasma con- centrations of histamine increased after antigen exposure (peak values occurred 5-15 min after a 20% reduction in FEV, was achieved), both at baseline (356±79 pg/ml) and during acute infection (350±48 pg/ml), but were not different. However, limited time point determinations were made and the concentration of ragweed antigen required to decrease the FEV1 by 20% was less during acute infection (Table III) . Effect ofR V infection on beta adrenergic function. To determine the effect of RV infection on airway beta adrenergic function, dose-dependent bronchodilation to isoproterenol was measured after induction of bronchoconstriction with histamine. Airway beta adrenergic response was quantitated by the concentration of inhaled isoproterenol required to achieve complete reversal of airway obstruction and the concentration of isoproterenol necessary to cause 50% of maximum bronchodilation (ED50). We found no change in airway response to beta adrenergic bronchodilation during the RV infection by either parameter (data not shown).
PMN cAMP response to isoproterenol. The increase in Ragweed Antigen E (,uIg/ml) that the viral infection alters the pattern of airway response to allergen challenge. These results confirm and extend previous observations using other model systems. Some (6, 28-30), but not all investigators (31, 32) , have demonstrated that viral upper respiratory tract infections in both normal and asthmatic individuals can enhance airway responsiveness to challenge with such chemical irritants as histamine or methacholine. However, the magnitude of the change in responsiveness may be affected by a'number of factors including the type and/or' strain of virus, the severity of the infection, and the age of the patient. To our knowledge, our data are the first to demonstrate enhanced airway responsiveness to both allergen and histamine inhalation challenge after the experimental induction of a symptomatic viral upper respiratory tract infection in allergic rhinitis patients.
Before viral infection, allergen provocation resulted in enhanced reactivity to histamine 24 h later. This increase in airway responsiveness persisted for < 2 wk in these patients with allergic rhinitis (Table IV) . Of interest, however, is that allergen challenge resulted in significant increases although 9 of 10 patients developed isolated immediate responses only. Previous work has suggested that the induction of late-phase asthmatic reactions is necessary for the subsequent development of enhanced airway reactivity (33, 34) . More recent work, however, has demonstrated that enhanced airway reactivity can be noted shortly after resolution of the immediate response (35) . Our data indicate that the late response is not essential for the generation of enhanced airway reactivity and more importantly, changes in the threshold of airway responses to irritant stimuli can be observed in nonasthmatic patients. These findings could explain seasonal intolerances to exercise or irritant exposures in many allergic rhinitis patients.
During clinically symptomatic viral infections, however, the pattern of pulmonary response to allergen challenge differed significantly from that seen before the infection. LARs were observed in 8 of 10 patients during the infection compared with 1 of 10 before infection. The increased frequency of LARs during the viral infection could not be correlated with PD20'values for histamine or antigen during this observation period or with changes in these values from baseline measurements before infection. Enhanced airway reactivity or changes in airway reactivity by themselves, therefore, were not responsible for the change in the pattern of airway response to allergen provocation. Our results are in agreement with previous work 'using both allergen' (36) and exercise (37) challenge in asthmatic patients in which baseline measurements of airway reactivity failed to correlate with the propensity to develop LARs. Although Crimi et al. (38) were able to determine a predictive index for LARs to house dust mite, this incorporated values for methacholine sensitivity, antigen-specific IgE in serum, and baseline FEVI. When airway sensitivity to methacholine alone was used, no correlation was found with the development of LARs. Thus, although viral infection increased the threshold response to both histamine and allergen, these changes can not account for the increased frequency of LARs observed both during infection and the convalescent period. Furthermore, the intensity of the immediate response to antigen did not predict the development of the LAR during either the baseline period or during the URI. 'Together, these results indicate that viral URIs increase the propensity to develop LARs after allergen exposure by mechanisms that are independent of changes in airway reactivity or the magnitude of the immediate response to challenge.
To ascertain which factors were influential in altering the pattern of response to challenge, a number of potential contributing mechanisms were analyzed. Decreased beta adrenerEffect ofRhinovirus Infection on Airway Reactivity and Late-Phase Asthma gic control of airway tone has been proposed as one important factor in asthma pathogenesis (8) . We have previously demonstrated that isolated leukocytes from asthmatic patients have diminished beta adrenergic responses (9); moreover, this response can be further diminished during viral respiratory infections in vivo (9) and after incubation with influenza virus (10) or rhinovirus (1 1) in vitro. In this series of experiments, however, we were unable to demonstrate a significant effect of RV infection on either the in vitro beta adrenergic response of isolated leukocytes or the in vivo airway response to isoproterenol. A number of factors may explain the differences between these results and those reported previously. First, in previous studies, in vitro beta adrenergic responsiveness was quantitated using a different model system (i.e., inhibition of granulocyte lysosomal enzyme release). Second, allergic rhinitis patients were evaluated in this report compared with asthmatic patients studied previously. Although a trend for diminished leukocyte beta adrenergic activity was noted, our results do not support a significant contribution of altered beta adrenergic responsiveness in PMNs or airway smooth muscle to the current observations. To determine the effects viral infection had on mediator release, measurements of both plasma histamine and basophil HR were performed. Although plasma histamine levels obtained before antigen challenge were higher during the infection compared with baseline values, the differences were not significant. Moreover, increases in histamine levels after allergen challenge were no different during infection compared with baseline measurements. Although these results suggest that pulmonary mast cell histamine release may not be augmented after allergen exposure during viral URIs, and that rises in levels of this mediator cannot account for the changes in pulmonary response patterns noted, there are certain limitations to these observations. First, direct quantitation ofpulmonary mast cell mediator release was not done and would be helpful in future studies to address this issue more specifically. Second, measurements of blood histamine levels after antigen challenge were limited in number and the dose of antigen required to decrease FEV1 during the acute infection was less than baseline. Third, histamine is but one mediator that can be released after mast cell activation (39) and further, its role in the development of the late-phase reaction in other target organs is felt to be minor (40, 41) . Since the precise pathogenesis ofLARs is still under study (42) , it remains to be established which mediator(s) will be important to measure as either predictors or markers of the various types of patterns of pulmonary responses observed after allergen challenge (43) .
In previous work, we have demonstrated that basophil histamine release is increased in asthma and that these increases correlate with measurements of airway reactivity in individual patients (44) . After in vitro incubation with influenza A virus, leukocyte histamine release is also enhanced, an effect that may be due, at least in part, to IFN production (15, 16) . Our present results extend our previous observations because they demonstrate that leukocyte HR is enhanced after in vivo infection with RV. Interestingly, the enhancement in leukocyte HR was noted only after exposure to ragweed antigen E. Direct measurement of cell-bound ragweed IgE antibody was not made; however, the total serum IgE antibody values were similar at baseline and URI. As serum IgE concentrations reflect basophil-bound antibody, this is an indirect suggestion that no change occurred in this parameter (45) . Together, these results
indicate that viral infection increases the intrinsic releasability of the basophilic leukocyte and that this process appears to be specific to antigen-triggered release events. Although the mechanisms underlying these changes remain to be established, it is of interest that these alterations coincided temporally with significant changes in the pattern of airway response to allergen challenge. Basophils have recently been considered to be an important participant in the generation of nasal late-phase reactions (41) . Although their role in LARs seems doubtful based on bronchoalveolar lavage studies in humans (17, 46, 47) 
